SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-037280
Filing Date
2022-11-10
Accepted
2022-11-10 06:37:04
Documents
14
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nuvl-8k_20221110.htm   iXBRL 8-K 35530
2 EX-99.1 nuvl-ex991_6.htm EX-99.1 173396
3 GRAPHIC gpt0kmtwrmmc000001.jpg GRAPHIC 8448
  Complete submission text file 0001564590-22-037280.txt   365259

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nuvl-20221110.xsd EX-101.SCH 5589
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvl-20221110_lab.xml EX-101.LAB 20063
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvl-20221110_pre.xml EX-101.PRE 11934
8 EXTRACTED XBRL INSTANCE DOCUMENT nuvl-8k_20221110_htm.xml XML 3675
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40671 | Film No.: 221374792
SIC: 2834 Pharmaceutical Preparations